The polymorphisms in the MGMT gene and the risk of cancer: A meta-analysis

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3227-3237

  Huang, Jin ^a   Du, Liang ^a   Wang, Haichuan ^a   Xiong, Tianyuan ^a   Ma, Yaxian ^a   Yang, Jiqiao ^a   Huang, Jichong ^a   Zeng, Dong ^a   Wang, Xiaoze ^a   Huang, He ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; MGMT; Polymorphisms

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MGMT GENE; ONCOGENE; PRIORITY JOURNAL;

EID: 84885434671     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0893-x     Document Type: Article

References (53)

1. Travis RC, Reeves GK, Green J, Bull D, Tipper SJ, Baker K, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet. 2010;375:2143-51.
2. Yang S, Jia C, Zhu H, Han S. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:2265-72.
3. Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, et al. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study. Mutat Res. 2011;708:11-20.
4. Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI, et al. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis. 2011;32:1855-61.
5. Liu J, Liao Q, Zhang Y, Sun S, Zhong C, Liu X. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:1467-76.
6. Chae MH, Jang JS, Kang HG, Park JH, Park JM, Lee WK, et al. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol Carcinog. 2006;45:239-49.
7. Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, et al. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis. 2007;28:665-71.
8. Crosbie PA, McGown G, Thorncroft MR, O'Donnell PN, Barber PV, Lewis SJ, et al. Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase. International journal of cancer Journal international du cancer. 2008;122:791-5.
9. Han J, Hankinson SE, De Vivo I. Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk. Carcinogenesis. 2006;27:2281-5.
10. Hazra A, Chanock S, Giovannucci E, Cox DG, Niu T, Fuchs C, et al. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study. Cancer Epidemiol Biomarkers Prev. 2008;17:311-9.
11. Huang J, Ye F, Chen H, Lu W, Xie X. Amino acid substitution polymorphisms of the DNA repair gene mgmt and the susceptibility to cervical carcinoma. Carcinogenesis. 2007;28:1314-22.
12. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, et al. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis. 2005;26:1354-9.
13. Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis. 2005;26:2131-7.
14. Yang M, Coles BF, Caporaso NE, Choi Y, Lang NP, Kadlubar FF. Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism. Lung Cancer. 2004;44:281-6.
15. Zhang Z, Wang L, Wei S, Liu Z, Wang LE, Sturgis EM, et al. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair. 2010;9:558-66.
16. Zhong Y, Huang Y, Huang Y, Zhang T, Ma C, Zhang S, et al. Effects of O6-methylguanine-DNA methyltransferase (MGMT) polymorphisms on cancer: a meta-analysis. Mutagenesis. 2010;25:83-95.
17. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer causes & control: CCC. 2010;21:289-300.
18. Akbari MR, Malekzadeh R, Shakeri R, Nasrollahzadeh D, Foumani M, Sun Y, et al. Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res. 2009;69:7994-8000.
19. Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, et al. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. International journal of cancer Journal international du cancer. 2008;123:174-80.
20. Dong X, Li Y, Chang P, Hess KR, Abbruzzese JL, Li D. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Mol Carcinog. 2012;51:491-9.
21. Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT, et al. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology. 2007;29:55-8.
22. Feng XX, Li ZF, Wang LB, Zhang JB, Lu ZX. Relationship between MGMT gene polymorphism and susceptibility of esophageal cancer. Zhong Guo Gong Gong Wei Sheng. 2008;24:697-9.
23. Gu S. Association of polymorphism of codon 53 in MGMT gene with susceptibility of non-small-cell-lung cancer in northern Chinese population. http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=0&CurRec=15&recid= &filename=2008062567.nh&dbname=CMFD2008&DbCode=CMFD&urlid= &yx=, 2008.
24. Han J, Tranah GJ, Hankinson SE, Samson LD, Hunter DJ. Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk. Pharmacogenet Genomics. 2006;16:469-74.
25. Huang SH, Chang PY, Liu CJ, Lin MW, Hsia KT. O6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2010;39:645-50.
26. Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, et al. Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14:1747-53.
27. Hung RJ, Baragatti M, Thomas D, McKay J, Szeszenia-Dabrowska N, Zaridze D, et al. Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007;16:2736-44.
28. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev. 2006;30:284-91.
29. Kaur TB, Travaline JM, Gaughan JP, Richie Jr JP, Stellman SD, Lazarus P. Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2000;9:339-42.
30. Khatami F, Noorinayer B, Mohebi SR, Ghiasi S, Mohebi R, Hashemi M, et al. Effects of amino acid substitution polymorphisms of two DNA methyltransferases on susceptibility to sporadic colorectal cancer. Asian Pacific journal of cancer prevention: APJCP. 2009;10:1183-8.
31. Kietthubthew S, Sriplung H, Au WW, Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health. 2006;209:21-9.
32. Li C, Liu J, Li A, Qian L, Wang X, Wei Q, et al. Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis. Cancer Lett. 2005;227:49-57.
33. 6-methylguanine-DNA methyltransferase (MGMT) gene in lung cancer patients from south china. Wei Sheng Du Li Xue Za Zhi. 2002;16:1-5.
34. Liu RQ, Zhuang ZX, He CH, He Y. Relationship between genetic polymorphisms of human O6-methylguanine-DNA methyltransferase (MGMT) gene. Ai Zheng Ji Bian Tu Bian. 2002;14:101-6.
35. Liu SH, Su M, Cheng L, Sun BL, Lu ZH. Polymorphisms of O6-methylguanine-DNA methyltransferase gene in Chinese Chaoshan esophageal cancer patients. Ai Zheng Ji Bian Tu Bian. 2006;18:100-4.
36. Loh YH, Mitrou PN, Bowman R, Wood A, Jeffery H, Luben RN, et al. MGMT Ile143val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. DNA Repair (Amst). 2010;9:421-8.
37. Loh YH, Mitrou PN, Wood A, Luben RN, McTaggart A, Khaw KT, et al. SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Cancer Epidemiol. 2011;35:369-74.
38. 6- methylguanine-DNA methyltransferase gene and gastric cancer hereditary susceptibility. Ji Bing Kong Zhi Za Zhi. 2006;10:222-5.
39. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006;12:2101-8.
40. O'Mara TA, Ferguson K, Fahey P, Marquart L, Yang HP, Lissowska J, et al. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk. Twin research and human genetics: the official journal of the International Society for Twin Studies. 2011;14:328-32.
41. Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569-75.
42. Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, et al. Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14:1703-9.
43. Shah MA, Shaff SM, Lone GN, Jan SM. Lack of influence of MGMT codon Leu84Phe and codon Ileu143Val polymorphisms on esophageal cancer risk in the Kashmir Valley. Asian Pacific journal of cancer prevention: APJCP. 2012;13:3047-52.
44. Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica. 2007;92:1180-5.
45. Shi JY, Ren ZH, Jiao B, Xiao R, Yun HY, Chen B, et al. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. International journal of cancer Journal international du cancer. 2011;128:233-8.
46. Stern MC, Conti DV, Siegmund KD, Corral R, Yuan JM, Koh WP, et al. DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007;16:2363-72.
47. Tranah GJ, Bugni J, Giovannucci E, Ma J, Fuchs C, Hines L, et al. O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States). Cancer causes & control: CCC. 2006;17:721-31.
48. Wang L, Liu H, Zhang Z, Spitz MR, Wei Q. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006;15:2364-9.
49. Yang F, Shi JY, Xu L, Ren LJ, Zhang QH, Zhao WL, et al. [Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2009;30:622-5.
50. Yu HJ. Genotype and phenotype study on cancer related genes in relation to esophageal squamous cell carcinoma in Yangzhong County, Jiangsu Province, China. http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=0&CurRec= 1&recid=&filename=2009183175.nh&dbname=CMFD2009&DbCode= CMFD&urlid=&yx=, 2009.
51. Yu L. The study on relationship between genetic polymorphisms of O6-methylguanine-DNA methyltransferase gene and esophageal cancer in Kazakh in Xinjiang. http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=4&CurRec= 8&recid=&filename=2009207794.nh&dbname=CMFD2012&DbCode= CMFD&urlid=&yx=, 2009.
52. Zhang M, Huang WY, Andreotti G, Gao YT, Rashid A, Chen J, et al. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17:2123-7.
53. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27:560-7.